Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 22752 | 16.94 |
09:34 ET | 3700 | 16.96 |
09:36 ET | 1200 | 16.945 |
09:38 ET | 3247 | 16.955 |
09:39 ET | 5850 | 17.005 |
09:41 ET | 13569 | 17.19 |
09:43 ET | 3219 | 17.01 |
09:45 ET | 1335 | 17.05 |
09:48 ET | 2223 | 17.02 |
09:50 ET | 1000 | 16.97 |
09:52 ET | 1815 | 16.995 |
09:54 ET | 2360 | 17.02 |
09:56 ET | 1015 | 17.02 |
09:57 ET | 1576 | 17.04 |
09:59 ET | 800 | 17.035 |
10:01 ET | 2236 | 17.01 |
10:03 ET | 1200 | 17.015 |
10:06 ET | 1400 | 17 |
10:08 ET | 12330 | 17.07 |
10:10 ET | 800 | 17.06 |
10:12 ET | 6083 | 17.04 |
10:14 ET | 3126 | 17.05 |
10:15 ET | 1600 | 17.08 |
10:17 ET | 2000 | 17.09 |
10:19 ET | 886 | 17.08 |
10:21 ET | 850 | 17.03 |
10:24 ET | 6051 | 17.05 |
10:26 ET | 2809 | 17.1099 |
10:28 ET | 5295 | 17.14 |
10:30 ET | 778 | 17.15 |
10:32 ET | 9953 | 17.0806 |
10:33 ET | 6517 | 17.18 |
10:35 ET | 1156 | 17.17 |
10:37 ET | 1424 | 17.165 |
10:39 ET | 1817 | 17.195 |
10:42 ET | 1354 | 17.19 |
10:44 ET | 1423 | 17.22 |
10:46 ET | 827 | 17.22 |
10:48 ET | 854 | 17.2 |
10:50 ET | 1661 | 17.2 |
10:51 ET | 800 | 17.21 |
10:53 ET | 1200 | 17.2 |
10:55 ET | 600 | 17.195 |
10:57 ET | 2050 | 17.1843 |
11:00 ET | 6192 | 17.23 |
11:02 ET | 5307 | 17.21 |
11:04 ET | 1764 | 17.26 |
11:06 ET | 3399 | 17.3 |
11:08 ET | 5386 | 17.29 |
11:09 ET | 3381 | 17.28 |
11:11 ET | 17058 | 17.29 |
11:13 ET | 2950 | 17.24 |
11:15 ET | 3065 | 17.215 |
11:18 ET | 1418 | 17.2 |
11:20 ET | 13060 | 17.175 |
11:22 ET | 5591 | 17.19 |
11:24 ET | 2528 | 17.22 |
11:26 ET | 1939 | 17.22 |
11:27 ET | 2200 | 17.22 |
11:29 ET | 300 | 17.215 |
11:31 ET | 561 | 17.2 |
11:33 ET | 3700 | 17.165 |
11:36 ET | 3671 | 17.21 |
11:38 ET | 2200 | 17.21 |
11:40 ET | 500 | 17.21 |
11:42 ET | 2347 | 17.16 |
11:44 ET | 1760 | 17.14 |
11:45 ET | 200 | 17.14 |
11:47 ET | 1711 | 17.115 |
11:49 ET | 1411 | 17.08 |
11:51 ET | 13073 | 17.11 |
11:54 ET | 4749 | 17.09 |
11:56 ET | 3081 | 17.095 |
11:58 ET | 4745 | 17.11 |
12:00 ET | 2707 | 17.105 |
12:02 ET | 2169 | 17.12 |
12:03 ET | 2915 | 17.14 |
12:05 ET | 1100 | 17.14 |
12:07 ET | 1000 | 17.145 |
12:09 ET | 500 | 17.16 |
12:12 ET | 700 | 17.17 |
12:14 ET | 400 | 17.17 |
12:16 ET | 1800 | 17.145 |
12:18 ET | 3806 | 17.15 |
12:20 ET | 2128 | 17.18 |
12:21 ET | 1768 | 17.18 |
12:23 ET | 2224 | 17.21 |
12:25 ET | 5963 | 17.21 |
12:27 ET | 2912 | 17.2 |
12:30 ET | 1757 | 17.19 |
12:32 ET | 1039 | 17.18 |
12:34 ET | 100 | 17.185 |
12:36 ET | 2418 | 17.18 |
12:38 ET | 1604 | 17.15 |
12:39 ET | 3100 | 17.15 |
12:41 ET | 2657 | 17.17 |
12:43 ET | 18031 | 17.205 |
12:45 ET | 23035 | 17.21 |
12:48 ET | 2450 | 17.185 |
12:50 ET | 450 | 17.19 |
12:52 ET | 6704 | 17.18 |
12:54 ET | 1645 | 17.18 |
12:56 ET | 2432 | 17.16 |
12:57 ET | 600 | 17.14 |
12:59 ET | 10903 | 17.04 |
01:01 ET | 4452 | 17 |
01:03 ET | 12522 | 17.04 |
01:06 ET | 4987 | 17.06 |
01:08 ET | 3447 | 17.11 |
01:10 ET | 2724 | 17.075 |
01:12 ET | 2131 | 17.08 |
01:14 ET | 1947 | 17.085 |
01:15 ET | 700 | 17.07 |
01:17 ET | 4145 | 17.08 |
01:19 ET | 6259 | 17.115 |
01:21 ET | 1580 | 17.09 |
01:24 ET | 1850 | 17.055 |
01:26 ET | 2861 | 17.05 |
01:28 ET | 1576 | 17.06 |
01:30 ET | 1005 | 17.065 |
01:32 ET | 7151 | 17.1 |
01:33 ET | 1400 | 17.115 |
01:35 ET | 17911 | 17.15 |
01:37 ET | 5690 | 17.145 |
01:39 ET | 19575 | 17.16 |
01:42 ET | 6006 | 17.15 |
01:44 ET | 6272 | 17.18 |
01:46 ET | 1573 | 17.18 |
01:48 ET | 1100 | 17.19 |
01:50 ET | 4601 | 17.17 |
01:51 ET | 1162 | 17.17 |
01:53 ET | 1110 | 17.16 |
01:55 ET | 3272 | 17.14 |
01:57 ET | 343 | 17.14 |
02:00 ET | 2071 | 17.14 |
02:02 ET | 5019 | 17.19 |
02:04 ET | 3258 | 17.25 |
02:06 ET | 3895 | 17.26 |
02:08 ET | 7506 | 17.33 |
02:09 ET | 9648 | 17.43 |
02:11 ET | 4770 | 17.34 |
02:13 ET | 5282 | 17.425 |
02:15 ET | 3456 | 17.44 |
02:18 ET | 5256 | 17.38 |
02:20 ET | 3824 | 17.34 |
02:22 ET | 2218 | 17.34 |
02:24 ET | 5201 | 17.32 |
02:26 ET | 2672 | 17.315 |
02:27 ET | 3759 | 17.34 |
02:29 ET | 1300 | 17.33 |
02:31 ET | 2092 | 17.31 |
02:33 ET | 3142 | 17.31 |
02:36 ET | 15611 | 17.31 |
02:38 ET | 4859 | 17.31 |
02:40 ET | 4443 | 17.39 |
02:42 ET | 4434 | 17.45 |
02:44 ET | 3444 | 17.46 |
02:45 ET | 3843 | 17.46 |
02:47 ET | 11359 | 17.46 |
02:49 ET | 15942 | 17.43 |
02:51 ET | 1679 | 17.46 |
02:54 ET | 3280 | 17.48 |
02:56 ET | 7910 | 17.48 |
02:58 ET | 6375 | 17.51 |
03:00 ET | 3635 | 17.5 |
03:02 ET | 3569 | 17.52 |
03:03 ET | 3421 | 17.51 |
03:05 ET | 5599 | 17.54 |
03:07 ET | 2247 | 17.55 |
03:09 ET | 1884 | 17.56 |
03:12 ET | 2512 | 17.55 |
03:14 ET | 2179 | 17.54 |
03:16 ET | 2590 | 17.52 |
03:18 ET | 2723 | 17.48 |
03:20 ET | 4239 | 17.43 |
03:21 ET | 7383 | 17.39 |
03:23 ET | 11190 | 17.39 |
03:25 ET | 5211 | 17.43 |
03:27 ET | 3875 | 17.46 |
03:30 ET | 4902 | 17.401 |
03:32 ET | 5465 | 17.39 |
03:34 ET | 3616 | 17.39 |
03:36 ET | 6262 | 17.3701 |
03:38 ET | 4213 | 17.335 |
03:39 ET | 6295 | 17.26 |
03:41 ET | 5063 | 17.245 |
03:43 ET | 2782 | 17.19 |
03:45 ET | 9402 | 17.19 |
03:48 ET | 6370 | 17.18 |
03:50 ET | 6434 | 17.21 |
03:52 ET | 10606 | 17.11 |
03:54 ET | 16281 | 17.085 |
03:56 ET | 13007 | 17.11 |
03:57 ET | 12315 | 17.07 |
03:59 ET | 47106 | 17.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.8B | -45.2x | --- |
Azenta Inc | 2.9B | -175.0x | --- |
Guardant Health Inc | 2.2B | -4.3x | --- |
PTC Therapeutics Inc | 2.5B | -4.4x | --- |
Amicus Therapeutics Inc | 3.0B | -20.3x | --- |
Genmab A/S | 18.6B | 30.4x | +22.71% |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
---|---|
Revenue (TTM) | $726.4M |
Shares Outstanding | 164.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $-0.38 |
Book Value | $2.62 |
P/E Ratio | -45.2x |
Price/Sales (TTM) | 3.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.